Blair Lapointe

Blair Lapointe has over 12 years of experience in the pharmaceutical industry.

Blair joined Merck’s Boston-based Discovery Chemistry group in 2009, holding positions of increasing responsibility while working in the areas of Immunology & Neuroscience.

In 2018, Blair transitioned to the Business Development and Licensing group, based out of Cambridge, MA, where he leads the negotiation of licensing and collaboration transactions for multiple therapeutic areas, modalities and technologies.

Blair holds a BS in Chemistry & a MS in Organic Chemistry from Northeastern University.